Analytical assay validation for acute myeloid leukemia measurable residual disease assessment by multiparametric flow cytometry

This is the authors' abstract. We don't add key points for this paper.

In this manuscript, we present the validation of an AML MFC-MRD assay using BM/PB patient specimens, adhering to best practices. Our approach is expected to assist other laboratories in expediting their validation activities to fulfill recent health authority guidelines.